Bloom Science to Present at Connecting Microbiome Communities Conference

SAN DIEGO, Calif., November 1, 2024 – Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that Sr. Scientist Lisa Elmén, Ph.D., will be presenting at the Connecting Microbiome Communities Conference being held November 3-6, 2024 in San Diego, CA.

Details are as follows:

• Connecting Microbiome Communities Conference
  Details: Dr. Elmén will deliver a scientific presentation titled: IrisRx: A Drug Discovery Platform to Develop Microbiota-based Therapeutics Targeting the Gut-Brain Axis
  Conference dates: November 3-6, 2024
  Presentation Timing: 1:15am PST on November 6, 2024

About Bloom Science, Inc. 

Bloom Science, Inc. is a clinical-stage biotech company focused on the development of novel first-in-class therapies for the treatment of metabolic and neurological disorders. Bloom’s research and development activities leverage its expertise in gut-brain axis biology, metabolism and the microbiome to develop innovative therapeutics designed to improve patients’ lives. Bloom’s clinical programs include BL-001, a first-in-class, orally delivered, Live Biotherapeutic Product (LBP) designed to replicate the therapeutic effects of the Ketogenic Diet. Bloom’s proprietary discovery platform, IrisRx™ enables a fundamentally different approach to developing medicines by harnessing our expanding insight into the Gut-Brain Axis to design and develop therapeutics that target novel biology with superior safety profiles. Bloom Science is advancing a deep pipeline of programs, focused in Obesity, Dravet syndrome and DEEs, Amyotrophic Lateral Sclerosis (ALS), and other neurodegenerative and cognitive disorders.